PPP1CB and neoplasm: Loss of PPM1B thus leads to sustained MYPT1 phosphorylation, reduced MP activity, and enhanced PRMT5 activation—a cascade that promotes tumorigenesis via epigenetic silencing of tumor suppressor genes.